Pulmonology CME

Pulmonary Medicine CME: Learn the Latest Advances

Speakers in this nationally acclaimed pulmonary medicine CME program deliver state-of-the-art information you can use. With The Brigham Board Review and Comprehensive Update in Pulmonary Medicine online CME course, you’ll learn how to employ optimal therapeutic strategies while reviewing the latest techniques for treating respiratory infections, lung diseases, interstitial disorders, vascular diseases, and more. It’s ideal for MOC and will help you to:

• Better understand clinical problems reflected in the ABIM pulmonary disease subspecialty board examination
• Effectively summarize major areas in pulmonary medicine, including respiratory physiology, genetics, and cell and molecular biology
• Competently evaluate pulmonary function testing, fundamental pulmonary imaging, and cardiopulmonary exercise testing

Expert Clinicians Share Lessons Learned from Medical Mishaps

What My Mistakes Taught Me is a truly unique and illuminating online CME program. In 22 one-hour lectures, physicians from different areas of medicine and surgery discuss the expertise they’ve gained from problems, mistakes, and errors in clinical practice.

Led by Martin A. Samuels, MD, these experienced clinicians share case studies and the take-away messages learned from their own medical mishaps, emphasizing that:

• While we’re not perfect, we’re still valued contributors to our profession and society
• Perceived mistakes help us live with our imperfections and strengthen our integrity
• Recognized mistakes tell us what works and what doesn’t
• Accepting mistakes helps us take responsibility for erroneous ideas or actions
• Open acknowledgement of mistakes inspires others to do likewise

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Medical videos & lectures explained clearly by world-class instructors.

Memorable illustrations, clinical scenarios, and passionate instructors set MedCram apart from other online medical lectures.

We prioritize the most important clinically relevant and practical information for clinical practice.

Understanding medicine has never been so simplified.

The BoardVitals Pulmonary and Critical Care Medicine CME Review offers clinicians 40 AMA PRA Category 1 Credits^TM, 40 ABIM MOC points, and over 600 Pulmonary and Critical Care Medicine board review questions. The questions cover key topics including infections, pulmonary disease, and neurologic disorders. This question bank will assist clinicians with Pulmonary and Critical Care Medicine certification and recertification.

The BoardVitals Pulmonary and Critical Care Medicine CME Review also features:

• Quick and Convenient CME
• Computer, phone, and tablet access
• Constantly updated up-to-date questions
• Questions that are targeted specifically to the exam
• Online CME tracker
• 100% Pass Guarantee
• Statistical comparison to other Pulmonary and Critical Care Medicine test-takers (Nationally)

After completing this activity, you should be able to:

• Provide guideline and knowledge-based approaches to critical care situations involving the management of complex cardiac and pulmonary disease
• Evaluate and manage common and uncommon mechanisms and functions of the pulmonary system
• Investigate the underlying pathophysiology of pulmonary disease and basic science knowledge

Target Audience: Clinicians focusing on Pulmonary and Critical Care Medicine

Target Audience: Physicians specializing in Cardiology, Chest Medicine, Family Medicine, Internal Medicine.

Pass the Pulmonary and Critical Care certification examinations with the BoardVitals Pulmonary Disease and Critical Care Medicine Board Review Question Bank. Targeted to the ABIM Pulmonary Disease Certification Exam as well as the ABIM/ABEM Critical Care Medicine Certification Exam, this board review question bank will help you pass your boards.

BoardVitals Pulmonary Disease and Critical Care Medicine Board Review Question Bank features:
• 700 Pulmonary Disease and Critical Care Medicine practice questions developed by top specialists dual certified in Pulmonary and Critical Care Medicine
• Detailed rationales for every exam question including explanations for incorrect responses
• Customize your practice by category to target weaknesses
• Earn up to 40 CME Credits and 40 ABIM MOC points with optional payment of $200
• 24/7 access from any computer, tablet or smartphone
• 100% Pass Guarantee

Target Audience:
This program is targeted to Pulmonary Disease specialists and Critical Care Medicine specialists preparing for specialty board exams.

In this online CME self-learning program: Systemic sclerosis (SSc) is a rare connective tissue disease that affects between eight and 56 people per million per year and up to 341 people per million total in the U.S., of whom around 70% will experience interstitial lung disease (ILD). The disease is characterized by a progressive course of scarring to the blood vessels underlying the skin, connective tissue, joints, and organs. The pathology of SSc remains to be fully elucidated, but different immunologic and genetic pathways have been explored as potential precipitating factors for SSc. Based on what is known, SSc-ILD may be summarized into three steps: 1) continuous injury to endothelial cells, 2) activation of innate and adaptive immunity, 3) recruitment and activation of fibroblasts. Early diagnosis is crucial for preservation and survival of major organs. Lung fibrosis is considered irreversible, and if the disease has progressed far beyond repair, lung transplantation is considered. Therefore, early detection is paramount in order for patients to preserve their lung function.

Target Audience:

The following HCPs: pulmonologists, rheumatologists, radiologists, primary care physicians, dermatologists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in pulmonology; and any other HCPs who have an interest in or otherwise clinically encounter patients with SSc-ILD.

By the end of the session the participant will be able to:

• Define the clinical features of systemic sclerosis
• Discuss current understanding of the biology of systemic sclerosis
• Define clinical phenotypes of systemic sclerosis
• Explore pulmonary manifestations of systemic sclerosis
• Understand the approach to diagnosis of systemic sclerosis interstitial lung disease and other pulmonary manifestations
See full details chevron_right

Activity Description / Statement of Need:
In this online, self-learning activity:

Hospital-acquired pneumonia (HAP) occurs at an estimated rate of five to ten per 1,000 hospital admissions and is the most common cause of hospital-acquired infection in the United States. It is defined as pneumonia that develops at least 48 hours after hospital admission and did not appear to be incubating at the time of admission. A significant subset of HAP that occurs most frequently in intensive care units (ICUs) is ventilator-associated pneumonia (VAP), which is defined as pneumonia that occurs more than 48 to 72 hours after tracheal intubation and is thought to affect approximately 10 to 20% of patients who receive mechanical ventilation for more than 48 hours. Altered mechanical defenses, such as impaired ciliary motion and mucus secretion, increase the susceptibility for acquiring pneumonia in intubated patients, with over 90% of pneumonia episodes that develop in ICUs occurring in patients who are intubated or mechanically ventilated.

Target Audience:
HCPs including: pulmonologists, infectious disease specialists, and intensivists; physician assistants, nurse practitioners, and pharmacists specializing in infectious disease or critical care; and any other healthcare professionals with an interest in or clinically encounter patients with HAP or VAP.

Activity Description / Statement of Need:

In this online, self-learning activity:

Alpha 1-antitrypsin deficiency (AATD), characterized by misfolded and lower function of the serine protease inhibitor alpha-1 antitrypsin (AAT), is a genetic disorder resulting in the degradation of lung structures. Reduced levels of AAT result in overactivity of neutrophil elastase, which destroys connectivetissue within the lung and causes degradation of alveoli, reduced pulmonary elastic recoil, and airflow. Breakdown of the alveoli eventually manifest as chronic obstructive lung disease (COPD), and otherassociated complications include liver disease, which occurs in about ten percent of patients with AATD.The most common cause of death in patients with severe AATD is respiratory failure, which accounts for45 to 72% of deaths.

Target Audience:

The following HCPs: pulmonologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in pulmonology and internal medicine; and any other healthcare professionals with an interest in or who clinically encounter patients with AATD.